NeuroRx, Inc.

Quick facts

Phase 3 pipeline

• Lurasidone Oral Capsule · Psychiatry/Neurology
  Lurasidone is an atypical antipsychotic that blocks dopamine D2 and serotonin 5-HT7 receptors to reduce psychotic symptoms and mood disturbances.
• NRX-101 Oral Capsule · Psychiatry / Neurology
  NRX-101 is a fixed-dose combination of d-cycloserine and lurasidone that modulates NMDA receptor function and dopamine/serotonin signaling to treat acute suicidality and bipolar depression.

Phase 2 pipeline

• Ketamine Intravenous Infusion

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• NeuroRx, Inc. portfolio CI brief
• NeuroRx, Inc. pipeline updates RSS